RESUMEN
A computer controlled dental anesthetic delivery system was studied with the OBJECTIVE of evaluating and comparing the unit to the traditional method of anesthetic delivery. The research design and METHOD of study involved the use of trained dentists who used both types of delivery systems on patients seen during their routine practice of dentistry. After the dental appointment was finished each dentist completed a survey concerning the injection. Patients completed a survey before the injection concerning their previous anesthetic experiences and completed another survey at the end of the dental appointment concerning the injection they had just received. Statistical analyses yielded RESULTS showing the two methods were rated very similarly by both patients and dentists. CONCLUSIONS resulting from the study are that computer controlled dental anesthetic injections and traditional anesthetic injections were accepted equally well by both dentists and patients.
Asunto(s)
Anestesia Dental/instrumentación , Anestesia Local/instrumentación , Actitud del Personal de Salud , Odontólogos/psicología , Satisfacción del Paciente , Adulto , Anestesia Dental/métodos , Anestesia Local/métodos , Anestésicos Locales/administración & dosificación , Ansiedad al Tratamiento Odontológico/prevención & control , Diseño de Equipo , Femenino , Estudios de Seguimiento , Humanos , Inyecciones/instrumentación , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Robótica , Adulto JovenRESUMEN
While the transactivation function of the tumor suppressor p53 is well understood, less is known about the transrepression functions of this protein. We have previously shown that p53 interacts with the corepressor protein mSin3a (hereafter designated Sin3) in vivo and that this interaction is critical for the ability of p53 to repress gene expression. In the present study, we demonstrate that expression of Sin3 results in posttranslational stabilization of both exogenous and endogenous p53, due to an inhibition of proteasome-mediated degradation of this protein. Stabilization of p53 by Sin3 requires the Sin3-binding domain, determined here to map to the proline-rich region of p53, from amino acids 61 to 75. The correlation between Sin3 binding and stabilization supports the hypothesis that this domain of p53 may normally be subject to a destabilizing influence. The finding that a synthetic mutant of p53 lacking the Sin3-binding domain has an increased half-life in cells, compared to wild-type p53, supports this premise. Interestingly, unlike retinoblastoma tumor suppressor protein, MDMX, and p14(ARF), Sin3 stabilizes p53 in an MDM2-independent manner. The ability of Sin3 to stabilize p53 is consistent with the model whereby these two proteins must exist on a promoter for extended periods, in order for repression to be an effective mechanism of gene regulation. This model is consistent with our data indicating that, unlike the p300-p53 complex, the p53-Sin3 complex is immunologically detectable for prolonged periods following exposure of cells to agents of DNA damage.
Asunto(s)
Cisteína Endopeptidasas/metabolismo , Complejos Multienzimáticos/metabolismo , Proteínas Nucleares , Proteínas Represoras/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Secuencia de Bases , Sitios de Unión , Línea Celular , Daño del ADN , Cartilla de ADN/genética , Estabilidad de Medicamentos , Humanos , Modelos Biológicos , Mutación Puntual , Prolina/química , Complejo de la Endopetidasa Proteasomal , Procesamiento Proteico-Postraduccional , Estructura Terciaria de Proteína , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-mdm2 , Proteínas Represoras/genética , Eliminación de Secuencia , Complejo Correpresor Histona Desacetilasa y Sin3 , Proteína p53 Supresora de Tumor/química , Proteína p53 Supresora de Tumor/genéticaRESUMEN
The MDM2 oncoprotein has transforming potential that can be activated by overexpression, and it represents a critical regulator of the p53 tumor suppressor protein. To identify other factors with a potential role in influencing the expression and/or function of MDM2, we utilized a yeast two-hybrid screening protocol. Here we report that MDM2 physically interacts with a structurally related protein termed MDMX. The results obtained in these studies provide evidence that C-terminal RING finger domains, contained within both of these proteins, play an important role in mediating the association between MDM2 and MDMX. The interaction of these proteins interferes with MDM2 degradation, leading to an increase in the steady-state levels of MDM2. MDMX also inhibits MDM2-mediated p53 degradation, with subsequent accumulation of p53. Taken together, these data indicate that MDMX has the potential to regulate the expression and function of the MDM2 oncoprotein.
Asunto(s)
Proteínas Nucleares , Proteínas Proto-Oncogénicas/metabolismo , Secuencia de Bases , Cartilla de ADN , Humanos , Unión Proteica , Conformación Proteica , Proteínas Proto-Oncogénicas/química , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-mdm2 , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/metabolismo , Técnicas del Sistema de Dos HíbridosRESUMEN
The p53 tumor suppressor protein can function as an activator and a repressor of gene transcription. Currently, the mechanism of transcriptional repression by p53 is poorly understood. To aid in clarifying this mechanism, we carried out studies designed to identify specific target genes that are down-regulated following p53 induction. Among the negative p53-response genes revealed by our screening protocols are those encoding stathmin (Op18), a tubulin-associated protein implicated in cell signaling pathways, and an FK506/rapamycin-binding protein, FKBP25. Stathmin and FKBP25 exhibit decreased expression in both human and murine immortalized and transformed cell lines following induction of wild-type p53 by several stimuli that result in DNA damage. Candidate p53-repressed genes such as these provide the necessary markers to delineate the mechanism and biological consequences of transcriptional repression mediated by p53.
Asunto(s)
Regulación hacia Abajo , Inmunofilinas/genética , Proteínas de Microtúbulos , Fosfoproteínas/genética , Proteínas de Unión a Tacrolimus , Proteína p53 Supresora de Tumor/metabolismo , Animales , Línea Celular , Humanos , Ratones , Estatmina , Células Tumorales CultivadasRESUMEN
Overexpression of oncoprotein MDM2 has been found in a significant number of human soft tissue tumors. In a subset of these tumors, overexpression is a result of enhanced translation of mdm2 mRNA. There are two transcripts from the mdm2 gene that differ only in their 5' leaders: a long form (L-mdm2) and a short form (S-mdm2) that arise from the use of different promoters. L-mdm2 mRNA contains two upstream open reading frames (uORFs) and this mRNA was loaded with ribosomes inefficiently in comparison with S-mdm2. The 5' leader of L-mdm2 was sufficient to transfer translational repression to a reporter gene and the two uORFs acted synergistically to achieve full suppression. In contrast, the 5' leader of S-mdm2 allowed efficient translation of an attached reporter gene in the tumor cells. These results are consistent with a model in which overexpression of MDM2 in certain tumors results from a change in mRNA structure due to a switch in promoter usage.
Asunto(s)
Regulación Neoplásica de la Expresión Génica , Proteínas Nucleares , Oncogenes , Biosíntesis de Proteínas , Proteínas Proto-Oncogénicas/genética , ARN Mensajero/genética , Regiones no Traducidas 5'/genética , Células Cultivadas , Coriocarcinoma/patología , Femenino , Fibroblastos/metabolismo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Células HeLa , Hormona de Crecimiento Humana/farmacología , Humanos , Pulmón/citología , Sistemas de Lectura Abierta , Regiones Promotoras Genéticas , Proteínas Proto-Oncogénicas/biosíntesis , Proteínas Proto-Oncogénicas c-mdm2 , Ribosomas/metabolismo , Células Tumorales Cultivadas/metabolismo , Neoplasias Uterinas/patologíaRESUMEN
There is growing evidence that the p53 tumor suppressor protein not only can function to activate gene transcription but also to repress the expression of specific genes. Although recent studies have implicated the transcriptional repression function of p53 in the pathway of apoptosis, the molecular basis of this activity remains poorly understood. This study takes a first step toward elucidating this mechanism. We report that trichostatin A (TSA), an inhibitor of histone deacetylases (HDACs), abrogates the ability of p53 to repress the transcription of two genes that it negatively regulates, Map4 and stathmin. Consistent with this finding, we report that p53 physically associates in vivo with HDACs. This interaction is not direct but, rather, is mediated by the corepressor mSin3a. Both wild-type p53 and mSin3a, but not mutant p53, can be found bound to the Map4 promoter at times when this promoter preferentially associates with deacetylated histones in vivo. Significantly, inhibition of p53-mediated transcriptional repression with TSA markedly inhibits apoptosis induction by p53. These data offer the first mechanistic insights for p53-mediated transcriptional repression and underscore the importance of this activity for apoptosis induction by this protein.
Asunto(s)
Regulación de la Expresión Génica , Histona Desacetilasas/metabolismo , Proteínas de Microtúbulos , Proteínas Nucleares , Proteínas Represoras/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Animales , Apoptosis , Sitios de Unión , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/genética , Daño del ADN , Inhibidores Enzimáticos/farmacología , Inhibidores de Histona Desacetilasas , Humanos , Ácidos Hidroxámicos/antagonistas & inhibidores , Ratones , Proteínas Asociadas a Microtúbulos/genética , Mutagénesis , Fosfoproteínas/genética , Regiones Promotoras Genéticas , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-mdm2 , Complejo Correpresor Histona Desacetilasa y Sin3 , Estatmina , Transcripción Genética , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/genéticaRESUMEN
We performed a prospective observational cohort study of the epidemiology and etiology of nosocomial pneumonia in 358 medical ICU patients in two university-affiliated hospitals. Protected bronchoscopic techniques (protected specimen brush and bronchoalveolar lavage) were used for diagnosis to minimize misclassification. Risk factors for ventilator-associated pneumonia were identified using multiple logistic regression analysis. Twenty-eight cases of pneumonia occurred in 358 patients for a cumulative incidence of 7.8% and incidence rates of 12.5 cases per 1, 000 patient days and 20.5 cases per 1,000 ventilator days. Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Hemophilus species made up 65% of isolates from the lower respiratory tract, whereas only 12.5% of isolates were enteric gram-negative bacilli. Daily surveillance cultures of the nares, oropharynx, trachea, and stomach demonstrated that tracheal colonization preceded ventilator-associated pneumonia in 93.5%, whereas gastric colonization preceded tracheal colonization for only four of 31 (13%) eventual pathogens. By multiple logistic regression, independent risk factors for ventilator- associated pneumonia were admission serum albumin <= 2.2 g/dl (odds ratio [OR] 5.9; 95% confidence interval [CI] 2.0-17.6; p = 0.0013), maximum positive end-expiratory pressure >= 7.5 cm H2O (OR, 4.6; 95% CI, 1.4 to 15.1; p = 0.012), absence of antibiotic therapy (OR, 6.7; 95% CI, 1.8 to 25.3; p = 0.0054), colonization of the upper respiratory tract by respiratory gram-negative bacilli (OR, 3.4; 95% CI, 1.1 to 10.1; p = 0.028), pack-years of smoking (OR, 2.3 for 50 pack-years; 95% CI, 1. 2 to 4.2; p = 0.012), and duration of mechanical ventilation (OR, 3. 4 for 14 d; 95% CI, 1.5 to 7.8; p = 0.0044). Several of these risk factors for ventilator-associated pneumonia appear amenable to intervention.
Asunto(s)
Broncoscopía , Infección Hospitalaria/epidemiología , Neumonía Bacteriana/epidemiología , Ventiladores Mecánicos/efectos adversos , Antibacterianos/uso terapéutico , Lavado Broncoalveolar , Broncoscopios , Broncoscopía/métodos , Estudios de Cohortes , Intervalos de Confianza , Cuidados Críticos , Enterobacteriaceae , Infecciones por Enterobacteriaceae/epidemiología , Infecciones por Haemophilus/epidemiología , Humanos , Incidencia , Modelos Logísticos , Nariz/microbiología , Oportunidad Relativa , Orofaringe/microbiología , Neumonía Neumocócica/epidemiología , Neumonía Estafilocócica/epidemiología , Respiración con Presión Positiva , Estudios Prospectivos , Infecciones por Pseudomonas/epidemiología , Pseudomonas aeruginosa , Factores de Riesgo , Albúmina Sérica/análisis , Fumar/epidemiología , Estómago/microbiología , Tennessee/epidemiología , Factores de Tiempo , Tráquea/microbiología , Ventiladores Mecánicos/microbiologíaRESUMEN
A prospective observational cohort study of nosocomial sinusitis was carried out in two medical intensive care units. Sinusitis was diagnosed by computed tomographic scanning and the culture of sinus fluid obtained by puncture of a maxillary sinus. Clinical and epidemiological data were collected at the time of admission to the unit and daily thereafter. Specimens from the nares, oropharynx, trachea, and stomach were cultured on admission and daily thereafter. The cumulative incidence of nosocomial sinusitis was 7.7%, and the incidence rates were 12 cases per 1,000 patient-days and 19.8 cases per 1,000 nasoenteric tube-days. Risk factors for nosocomial sinusitis, as determined by multiple logistic regression analysis, included nasal colonization with enteric gram-negative bacilli (odds ratio [OR], 6.4; 95% confidence interval [95% CI], 2.2-18.8; P = .007), feeding via nasoenteric tube (OR, 14.1; 95% CI, 1.7-117.6; P = .015), sedation (OR, 15.9; 95% CI, 1.9-133.5; P = .011), and a Glasgow coma score of < or = 7 (OR, 9.1; 95% CI, 3.0-27.3; P = .0001).
Asunto(s)
Infección Hospitalaria/epidemiología , Unidades de Cuidados Intensivos , Sinusitis/epidemiología , Estudios de Cohortes , Infección Hospitalaria/diagnóstico por imagen , Infección Hospitalaria/microbiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Senos Paranasales/diagnóstico por imagen , Senos Paranasales/microbiología , Estudios Prospectivos , Radiografía , Factores de Riesgo , Sinusitis/diagnóstico por imagen , Sinusitis/microbiologíaRESUMEN
Oncoprotein MDM2 inhibits p53-dependent cell cycle arrest and apoptosis. MDM2-overexpressing human cancer cell lines (n = 3) were found to be resistant to growth inhibition after infection by p53-expressing adenovirus (Ad-p53), as compared to low MDM2-expressing tumors (n = 3), in vitro. The growth of MDM2-overexpressing tumors, however, was inhibited by p21-expressing adenovirus (Ad-p21) infection, and the cyclin-dependent kinase-inhibitory region of p21 was sufficient to bypass the MDM2-p53 feedback loop. The phosphorylation state of Rb correlated with the response to either p53 or p21 gene therapy. MDM2-overexpressing cancer cells infected by Ad-p21 also developed a quiescent large-cell morphology. The results suggest that MDM2-mediated resistance to p53 may be bypassed by p21 and that the Rb phosphorylation state may predict the effects on growth after Ad-p53 or Ad-p21 infection.
Asunto(s)
Genes p53/fisiología , Terapia Genética , Neoplasias/terapia , Proteínas Nucleares , Proteínas Proto-Oncogénicas/fisiología , Adenoviridae/genética , División Celular , Supervivencia Celular , Humanos , Fosforilación , Proteínas Proto-Oncogénicas/análisis , Proteínas Proto-Oncogénicas c-mdm2 , Proteína de Retinoblastoma/metabolismo , Células Tumorales CultivadasRESUMEN
The mdm2 oncogene has transforming potential that is activated by overexpression. We previously reported the identification of human choriocarcinoma cell lines that have very high levels of mdm2 proteins as well as elevated levels of a stabilized wild-type p53 protein. Importantly, this mdm2 overexpression resulted from enhanced translation of mdm2 mRNA, a mechanism that had not previously been implicated in mdm2 expression control. The focus of this study was to investigate the breadth of enhanced translation of mdm2 mRNA in human cancers and to elucidate the basis for this translational activation. Here we present evidence that translational enhancement of mdm2 expression occurs in a variety of human tumor cells. Most of these samples also have high levels of wild-type p53 protein. However, there is no evidence for concomitant overexpression of the p53 target genes p21/waf1 and gadd45. Additionally, we demonstrate that the translational enhancement of mdm2 involves a preferential increase in mdm2 transcription that is initiated from the internal p53-responsive promoter region of this gene. The particular mdm2 transcripts that are generated contain a distinct 5' untranslated region and exhibit a significantly enhanced translational efficiency. These data provide a quantitative explanation for the overexpression of mdm2 proteins in this class of human tumors.
Asunto(s)
Proteínas de Neoplasias/genética , Neoplasias/genética , Proteínas Nucleares , Biosíntesis de Proteínas , Proteínas Proto-Oncogénicas/genética , ARN Mensajero/metabolismo , Transcripción Genética , Secuencia de Bases , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/metabolismo , ADN Complementario/análisis , Genes p53/genética , Humanos , Péptidos y Proteínas de Señalización Intracelular , Melanoma/genética , Melanoma/metabolismo , Datos de Secuencia Molecular , Mutación , Proteínas de Neoplasias/metabolismo , Neoplasias/metabolismo , Reacción en Cadena de la Polimerasa , Proteínas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-mdm2 , ARN/análisis , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/metabolismo , Proteinas GADD45RESUMEN
Meningiomas represent a common class of tumors of the central nervous system. However, the molecular events underlying their formation are poorly understood. Because altered expression of the p53 tumor suppressor gene and the mdm2 proto-oncogene have been demonstrated in a wide variety of tumors, we carried out studies to assess the possible involvement of these two genes in meningioma tumorigenesis. We used Western blot analysis to examine the level of expression of the mdm2 and p53 proteins in a series of sixteen primary meningiomas and four meningioma cell lines. The data obtained from these studies suggest that elevated expression of the p53 or mdm2 protein products does not represent a common event in the development of human meningiomas.
Asunto(s)
Regulación Neoplásica de la Expresión Génica/fisiología , Genes p53/genética , Neoplasias Meníngeas/metabolismo , Meningioma/metabolismo , Proteínas Nucleares , Proteínas Proto-Oncogénicas/biosíntesis , Proto-Oncogenes/genética , Western Blotting , Humanos , Neoplasias Meníngeas/genética , Meningioma/genética , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-mdm2 , Células Tumorales CultivadasRESUMEN
Physicians need to become committed to promoting the preventive benefits of regular physical activity. Practical strategies can help physicians efficiently and effectively incorporate exercise counseling into their practices. These strategies include regularly asking about leisure activity and linking the agenda of an office visit to the benefits of exercise. The physician and the patient should work together to formulate a mutually acceptable plan for the patient to adopt and maintain a healthful exercise lifestyle. In the same way that prescriptions are written for medications, a prescription can be given for an exercise plan suited to the individual patient.
Asunto(s)
Ejercicio Físico , Educación del Paciente como Asunto , Atención Primaria de Salud , Humanos , Estados UnidosRESUMEN
Pneumonia is the most commonly reported nosocomial infection in ICU patients, occurring predominantly in patients whose lungs are ventilated, at a rate of 1% to 3% per day of mechanical ventilation. Substantially increased costs and mortality have been attributed to nosocomial pneumonia. Our understanding of the epidemiology of nosocomial pneumonia in ICU populations has been limited by the reliance of most published studies on clinical diagnostic criteria, which are nonspecific. In addition to mechanical ventilation and tracheal intubation, other suspected risk factors of importance include chronic lung disease, age, severity of illness, upper abdominal or thoracic surgery, head trauma or depressed level of consciousness, and gastric acid inhibition. Aspiration appears to be the primary mode of inoculation of microorganisms into the distal lung; however, the relative importance of different sites as reservoirs for aspiration is controversial. It is hoped that studies based on improved diagnostic techniques, such as quantitative cultures of protected brush or bronchoalveolar lavage specimens, will provide the basis for an improved understanding of the epidemiology and prevention of this important infection in critically ill patients.
Asunto(s)
Infección Hospitalaria/epidemiología , Unidades de Cuidados Intensivos , Neumonía/epidemiología , Costo de Enfermedad , Humanos , Incidencia , Neumonía/economía , Neumonía/mortalidad , Neumonía Bacteriana/microbiología , Neumonía Viral/virología , Respiración Artificial/efectos adversos , Factores de RiesgoRESUMEN
To better understand the molecular mechanisms responsible for meningioma tumorigenesis we previously utilized subtractive hybridization protocols to identify genes the expression or structure of which is altered in these common brain tumors. Here we show that a CA dinucleotide repeat element present in one complementary DNA isolated by this approach has undergone a contraction in size in a meningioma cell line. Extension of this initial observation has revealed widespread genetic alterations affecting simple repeat sequences in this and other meningiomas. These data indicate that genetic instability may play a previously unrecognized role in the etiology of meningiomas.
Asunto(s)
ADN de Neoplasias/genética , ADN Satélite/genética , Neoplasias Meníngeas/genética , Meningioma/genética , Secuencia de Bases , Humanos , Datos de Secuencia Molecular , Fenotipo , Reacción en Cadena de la Polimerasa , Células Tumorales CultivadasRESUMEN
The cellular mdm2 gene, which has potential transforming activity that can be activated by overexpression, is amplified in a significant percentage of human sarcomas and in other mammalian tumors. Proteins encoded by the mdm2 gene can bind to, and inhibit the function of, the protein product of the p53 tumor suppressor gene. As reported here, we have identified human choriocarcinoma cell lines that express high levels of mdm2 proteins as well as the p53 protein. Several lines of evidence demonstrate that the p53 in these tumor cells has a wild-type nucleotide sequence, although the protein exhibits an extended half-life. Further, the more than 100-fold overexpression of mdm2 proteins in these cells cannot be explained by gene amplification, elevated RNA expression, or altered protein stability; rather our data indicate that elevated mdm2 protein levels in these choriocarcinoma cell lines result from enhanced translation. This mechanism has not previously been implicated in the regulation of mdm2 gene expression, and it represents a novel means by which the potential transforming activity of the mdm2 oncogene could be activated.
Asunto(s)
Coriocarcinoma/genética , Proteínas de Neoplasias/genética , Proteínas Nucleares , Oncogenes , Biosíntesis de Proteínas , Proteínas Proto-Oncogénicas , Secuencia de Bases , Coriocarcinoma/metabolismo , Semivida , Humanos , Datos de Secuencia Molecular , Proteínas de Neoplasias/biosíntesis , Proteínas Proto-Oncogénicas c-mdm2 , Proteína p53 Supresora de Tumor/biosíntesisRESUMEN
Cytogenetic and molecular analyses of human breast cancer cells have identified consistent losses of specific chromosomal regions in these tumors, suggesting that such regions harbor tumor suppressor genes whose homozygous loss or inactivation directly contributes to tumorigenesis. To date, deletions of chromosome 8 sequences have been described infrequently and only in low percentages of breast carcinomas. We report the identification of a new DNA marker on chromosome 8p that is deleted in 6 (75%) of 8 breast carcinoma cell lines and in 1 primary breast carcinoma examined. No deletion of this marker was detected in any normal or nonbreast carcinoma cell lines analyzed. Southern blot and fluorescence in situ hybridization studies indicate that this clone maps to chromosome 8 between bands p12 and p21. These observations suggest that a new gene, whose loss or inactivation may foster breast carcinoma tumorigenesis, may reside in this chromosome 8p region.
Asunto(s)
Neoplasias de la Mama/genética , Cromosomas Humanos Par 8 , Eliminación de Secuencia , Secuencia de Bases , Mapeo Cromosómico , Sondas de ADN , Humanos , Hibridación Fluorescente in Situ , Datos de Secuencia Molecular , Células Tumorales CultivadasRESUMEN
The mouse c-Ki-ras protooncogene promoter contains an unusual DNA element consisting of a 27 bp-long homopurine-homopyrimidine mirror repeat (H-motif) adjacent to a d(C-G)5 repeat. We have previously shown that in vitro these repeats may adopt H and Z conformations, respectively, causing nuclease and chemical hypersensitivity. Here we have studied the functional role of these DNA stretches using fine deletion analysis of the promoter and a transient transcription assay in vivo. We found that while the H-motif is responsible for approximately half of the promoter activity in both mouse and human cell lines, the Z-forming sequence exhibits little, if any, such activity. Mutational changes introduced within the homopurine-homopyrimidine stretch showed that its sequence integrity, rather than its H-forming potential, is responsible for its effect on transcription. Electrophoretic mobility shift assays revealed that the putative H-motif tightly binds several nuclear proteins, one of which is likely to be transcription factor Sp1, as determined by competition experiments. Southwestern hybridization studies detected two major proteins specifically binding to the H-motif: a 97 kD protein which presumably corresponds to Sp1 and another protein of 60 kD in human and 64 kD in mouse cells. We conclude that the homopurine-homopyrimidine stretch is required for full transcriptional activity of the c-Ki-ras promoter and at least two distinct factors, Sp1 and an unidentified protein, potentially contribute to the positive effect on transcription.
Asunto(s)
Genes ras , Regiones Promotoras Genéticas , Purinas/química , Pirimidinas/química , Secuencias Repetitivas de Ácidos Nucleicos , Transcripción Genética , Secuencia de Bases , Sitios de Unión , ADN Superhelicoidal/química , ADN Superhelicoidal/metabolismo , Células HeLa , Humanos , Datos de Secuencia Molecular , Mutagénesis , Proteínas Nucleares/metabolismo , Conformación de Ácido Nucleico , Factor de Transcripción Sp1/metabolismo , Relación Estructura-Actividad , Células Tumorales CultivadasRESUMEN
Neurofibromatosis type 2 (NF2) is an autosomal dominantly-inherited disorder predisposing affected individuals to tumors of multiple cell types in the central nervous system, including meningiomas. A candidate tumor suppressor gene for this disorder has recently been cloned; the protein product of this gene has a predicted role in linking integral membrane proteins with the cytoskeleton. Utilizing reverse transcription-polymerase chain reaction (RT-PCR) analyses, we have identified a number of alternatively spliced transcription products encoded by the NF2 gene. These alternative splice variants were detected in RNA isolated from several sources, including primary leptomeningeal tissue and an established line of leptomeningeal cells (LMC). Several of these variants delete previously identified coding regions of this gene. Moreover, two of these splice variants add previously unrecognized exons to the NF2 coding region. These identified splice forms will serve as natural reagents for the functional dissection of the NF2 protein product(s). They also should be considered in studies investigating mutations of this gene in members of NF2 families and in tumor analyses.
Asunto(s)
Regulación Neoplásica de la Expresión Génica , Genes de la Neurofibromatosis 2 , Proteínas de la Membrana/genética , Neoplasias Meníngeas/genética , Meningioma/genética , Proteínas de Neoplasias/genética , Empalme del ARN , ARN Mensajero/genética , Secuencia de Aminoácidos , Secuencia de Bases , Línea Celular , Análisis Mutacional de ADN , ADN de Neoplasias/genética , ADN de Cadena Simple/genética , Exones , Humanos , Proteínas de la Membrana/biosíntesis , Neoplasias Meníngeas/metabolismo , Meninges/metabolismo , Meningioma/metabolismo , Datos de Secuencia Molecular , Proteínas de Neoplasias/biosíntesis , Neurofibromatosis 2/genética , Neurofibromina 2 , Reacción en Cadena de la Polimerasa , Polimorfismo Genético , Células Tumorales CultivadasRESUMEN
The mdm2 oncogene, which is often amplified in mammalian tumors, produces a number of transcripts that encode distinct protein forms. Previous studies demonstrating that overexpression of the mdm2 gene can activate its transforming potential, and can inhibit the transcriptional activation function of p53, prompted us to begin to explore possible functional differences among the various mdm2 products. Utilizing a transient transfection assay, we have evaluated four naturally occurring murine mdm2 forms for their ability to inhibit p53-mediated transcriptional activation of reporter genes regulated by p53 response elements. Three of these mdm2 forms were found to physically associate with the wild-type p53 protein and to possess the ability to inhibit its transactivation function. A fourth form failed to exhibit either of these functions. This last mdm2 form lacks the N-terminal protein domain that is present in the other three splice forms examined, pointing to this region as one that is critical for complex formation with the p53 protein. Identifying such differences among mdm2 proteins provides important clues for dissecting their functional domains, and emphasizes that defining the individual properties of these products will be critical in elucidating the overall growth control function of the mdm2 gene.
Asunto(s)
Proteínas de Neoplasias/metabolismo , Proteínas Nucleares , Proteínas Proto-Oncogénicas , Proteína p53 Supresora de Tumor/metabolismo , Empalme Alternativo , Animales , Carcinoma de Pulmón de Células no Pequeñas , Línea Celular , Cloranfenicol O-Acetiltransferasa/biosíntesis , Cloranfenicol O-Acetiltransferasa/metabolismo , Eliminación de Gen , Humanos , Luciferasas/biosíntesis , Luciferasas/metabolismo , Neoplasias Pulmonares , Ratones , Proteínas de Neoplasias/biosíntesis , Oncogenes , Proteínas Proto-Oncogénicas c-mdm2 , ARN Mensajero/metabolismo , Transcripción Genética , Transfección , Células Tumorales CultivadasRESUMEN
The p53 tumor suppressor gene product can complex with polypeptides encoded by the mdm2 putative protoncogene. In addition, mdm2 mRNA levels have been shown to increase following the activation of wild type (wt) p53. To determine the basis for the effect of wt p53 on mdm2 mRNA, we studied the interaction of the mdm2 gene with p53. We report that wt p53 can bind sequence-specifically to a DNA region residing downstream to exon 1 of the mdm2 gene. This is correlated with a pronounced p53-dependent transcriptional activation. Efficient p53-dependent transactivation can be obtained with an mdm2 genomic DNA fragment lacking the putative mdm2 promoter. These findings suggest that p53 can induce transcription from an internal promoter located within the mdm2 gene. These findings raise the possibility that, in addition to increasing the overall levels of mdm2 mRNA, wt p53 may also modulate the repertoire of mdm2 transcripts present within the cell.